Parrish, AReubenson, GBlockman, MCohen, KGray, AKredo, TDe Waal, RNel, JRees, H2024-09-252024-09-252021-11-05https://www.health.gov.za/wp-content/uploads/2021/11/Rapid-review-of-Fluvoxamine-for-COVID-19_5November2021.pdfhttps://hdl.handle.net/11288/597487A rapid review of available evidence on the efficacy and safety of fluvoxamine in patients with COVID-19.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Serotonin Reuptake InhibitorMortalityRapid reviewAntidepressantCOVID-19 treatmentFluvoxamineTechnical Report